Mycology
In recent years, the incidence of fungal infections has increased dramatically, especially in immunocompromised patients. Numerous studies have shown that early initiation of appropriate antifungal therapy is crucial for reducing mortality.
In our laboratory, we perform identification by molecular sequencing of specific targets for cryptic species of the genera Aspergillus, Fusarium and Scedosporium, these molds being more and more frequently responsible of invasive fungal infections.
Susceptibility to antifungals varies according to the genus and species of the fungal agent. Fungal taxonomy is evolving, thus the identification methods need to be faster and more accurate.
Affiliations
